According to new American Gastroenterological Association guidelines on use of biomarkers to help manage Crohn disease endoscopic evaluation to rule out active inflammation after resolution of symptoms and normalization of biomarkers should occur:
Capsule-sponge DNA methylation test boosts Barrett’s screening access, showing high accuracy, strong tolerability, and promise for primary care triage to endoscopy.
Post hoc LUCENT-2 and VIVID-1 analyses show more mirikizumab-treated patients reached steroid-free composite remission in UC and Crohn disease at 1 year.
Rotavirus vaccine uptake declines under shared clinical decision-making could add up to 4500 infant hospitalizations per birth cohort, a new model projects.
AHA 2026: Yoga-based cardiac rehabilitation improved quality of life and walking distance in patients with HFrEF but did not significantly reduce death, hospitalization, or stroke.